Authors reported that patients administered oral THC experienced a “nine-fold greater reduction in opioid consumption” compared to controls.
The administration of oral THC mitigates symptoms of post-traumatic stress syndrome (PTSD), according to clinical trial data published online ahead of print in the journal Clinical Drug Investigation. Researchers reported, “The intervention caused a statistically significant improvement in global symptom severity, sleep quality, frequency of nightmares, and PTSD hyperarousal symptoms.” They concluded, “Orally absorbable delta-9-THC was safe and well tolerated by patients with chronic PTSD.”
The results of a first-of-its-kind worldwide survey of nearly 1,000 medicinal cannabis consumers shows that most patients prefer their medicine in the way that nature, not Big Pharma, intended it to be. Overall, subjects said that herbal cannabis preparations were more cost-effective and posed fewer side-effects than cannabis-derived pharmaceuticals.
As 50% of Americans now support marijuana legalization, the prohibitionists are coming out in full force…
“Where Do You Get ‘It’ From?” Author: Publius* Most patients don’t get asked where they…
This informative article from CBS News about the government’s claim that there is no need for medical patients to access cannabis, when there is a ‘fake’ cannabis pill on the market, features remarks from NORML advisory board member, professor and author
However, special testing techniques have been developed that make it possible to distinguish the two by testing for non-standard cannabinoids that appear in marijuana but not Marinol.
Investigators at the University of Mississippi report the discovery of eleven new non-cannabinoid constituents in cannabis, several of which possess “anti-microbial” (think MRSA), “anti-malarial,” and “anti-leishmanial” (a common skin parasite) activity. Scientists also reported that several of the compounds also possessed anti-inflammatory properties and acted as potent anti-oxidants.